Clinical Trial Update: NOV-002, Doxorubicin, Cyclophosphamide, and Docetaxel in Women With Newly Diagnosed Stage II or IIIC Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating NOV-002 in combination with doxorubicin, cyclophosphamide, and docetaxel for newly diagnosed stage II or IIIC breast ca…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• Doxorubicin (doxorubicin)
• NOV-002

Snippet

Sponsor: University of Miami | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-03-29